why choose us

First received: February 28, 2023

Clinical Trial: Safety and Efficacy of PMT Therapy of hPAP

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hereditary Pulmonary Alveolar Proteinosis

Study Type: INTERVENTIONAL


Official Title: A First-In-Human Clinical Trial of Lentiviral-mediated CSF2RA Gene Transfer/Pulmonary Macrophage Transplantation Therapy of Hereditary Pulmonary Alveolar Proteinosis

Brief Summary: The major goal of this study is to evaluate a new type of cell transplantation therapy for individuals with hereditary PAP, study a new treatment that may be useful for treatment of other diseases, and research mechanisms that drive the development and function of lung macrophages.

Read more